Two Sigma Investments, LP Arrowhead Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 794,373 shares of ARWR stock, worth $12 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

794,373

Previous 208,311 281.34%

Holding current value

$12 Million

Previous $4.03 Million 270.39%

% of portfolio

0.04%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$17.7 - $26.34 $10.4 Million - $15.4 Million	586,062 Added 281.34%	794,373 $14.9 Million
Q3 2024 Nov 14, 2024	BUY	$19.36 - $29.54 $387,161 - $590,740	19,998 Added 10.62%	208,311 $4.03 Million
Q2 2024 Aug 14, 2024	BUY	$21.87 - $28.24 $3.39 Million - $4.38 Million	155,011 Added 465.47%	188,313 $4.89 Million
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $201,354 - $292,152	7,400 Added 28.57%	33,302 $952,000
Q4 2023 Feb 14, 2024	SELL	$21.2 - $31.03 $5.13 Million - $7.51 Million	-242,032 Reduced 90.33%	25,902 $792,000
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $1.13 Million - $1.56 Million	-43,106 Reduced 13.86%	267,934 $7.2 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $5.55 Million - $9.13 Million	220,740 Added 244.45%	311,040 $11.1 Million
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $1.81 Million - $2.94 Million	76,355 Added 547.54%	90,300 $2.29 Million
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $390,460 - $565,609	13,945 New	13,945 $565,000
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $1.01 Million - $1.83 Million	36,257 Added 546.95%	42,886 $1.51 Million
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $262,640 - $463,831	6,629 New	6,629 $305,000
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $4.33 Million - $6.3 Million	-74,200 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $1.39 Million - $2.02 Million	22,338 Added 43.07%	74,200 $6.15 Million
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $3.18 Million - $4.69 Million	51,862 New	51,862 $3.44 Million
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $1.06 Million - $1.63 Million	-31,787 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $14.1 Million - $23.4 Million	-540,616 Reduced 94.45%	31,787 $1.37 Million
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $8.55 Million - $26.3 Million	415,952 Added 265.87%	572,403 $16.5 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $4.4 Million - $11.4 Million	156,451 New	156,451 $9.92 Million
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $2.53 Million - $4.63 Million	-235,216 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.0 - $20.3 $3.29 Million - $4.77 Million	235,216 New	235,216 $4.51 Million
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $1.2 Million - $2.64 Million	188,364 New	188,364 $2.56 Million
Q1 2018 May 15, 2018	SELL	$3.72 - $7.64 $147,780 - $303,506	-39,726 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.14 - $4.5 $124,739 - $178,767	39,726	39,726 $146,000

Others Institutions Holding ARWR

# of Institutions

304

Shares Held

95.9M

Call Options Held

523K

Put Options Held

493K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.6B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Arrowhead Pharmaceuticals, Inc. Transaction History